{"entity":{"type":"insider","cik":"0001360548","url":"/insider/0001360548","json_url":"/insider/0001360548.json","name":"Tulipano Stephen J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":5,"first":"2010-05-05","last":"2024-03-19","span_basis":"filed_date"},"name_variants":[{"name":"Tulipano Stephen J","source":"filing","n_filings":5,"first_seen":"2010-05-05","last_seen":"2024-03-19"}],"transactions":[{"id":2899070,"accession":"0001415889-24-008690","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-008690","line_url":"/filing/0001415889-24-008690#line-2","is_derivative":false,"issuer_cik":"0001360548","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001360548","owner_cik":"0001360548","owner_name":"Tulipano Stephen J","owner_display_name":"Tulipano Stephen J","owner_url":"/insider/0001360548","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4116.0,"shares_display":"4,116","price_per_share":6.0986,"price_display":"6.10","price_state":"stated","total_value":25101.8376,"total_display":"25,101.84","total_whole":"25,102","shares_owned_after":20746.0,"shares_owned_after_display":"20,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-19","filed_date":"2024-03-19","scope":"insider"},{"id":5145784,"accession":"0001209191-21-013897","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-013897","line_url":"/filing/0001209191-21-013897#line-6","is_derivative":false,"issuer_cik":"0001360548","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001360548","owner_cik":"0001360548","owner_name":"Tulipano Stephen J","owner_display_name":"Tulipano Stephen J","owner_url":"/insider/0001360548","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":58.5983,"price_display":"58.60","price_state":"stated","total_value":292991.5,"total_display":"292,991.50","total_whole":"292,992","shares_owned_after":602.0,"shares_owned_after_display":"602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-23","filed_date":"2021-02-24","scope":"insider"},{"id":5145778,"accession":"0001209191-21-013897","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-013897","line_url":"/filing/0001209191-21-013897","is_derivative":false,"issuer_cik":"0001360548","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001360548","owner_cik":"0001360548","owner_name":"Tulipano Stephen J","owner_display_name":"Tulipano Stephen J","owner_url":"/insider/0001360548","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":58.916171576,"price_display":"58.92","price_state":"stated","total_value":1472904.2894,"total_display":"1,472,904.29","total_whole":"1,472,904","shares_owned_after":10400.0,"shares_owned_after_display":"10,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-22","filed_date":"2021-02-24","scope":"insider","n_lines":3},{"id":2883503,"accession":"0001209191-20-056953","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-20-056953","line_url":"/filing/0001209191-20-056953","is_derivative":false,"issuer_cik":"0001360548","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001360548","owner_cik":"0001360548","owner_name":"Tulipano Stephen J","owner_display_name":"Tulipano Stephen J","owner_url":"/insider/0001360548","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33268.0,"shares_display":"33,268","price_per_share":40.79624917037393,"price_display":"40.80","price_state":"stated","total_value":1357209.6174,"total_display":"1,357,209.62","total_whole":"1,357,210","shares_owned_after":16929.0,"shares_owned_after_display":"16,929","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-04","filed_date":"2020-11-04","scope":"insider","n_lines":3},{"id":2883489,"accession":"0001209191-20-056953","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-056953","line_url":"/filing/0001209191-20-056953#line-6","is_derivative":false,"issuer_cik":"0001360548","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001360548","owner_cik":"0001360548","owner_name":"Tulipano Stephen J","owner_display_name":"Tulipano Stephen J","owner_url":"/insider/0001360548","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1732.0,"shares_display":"1,732","price_per_share":39.8369,"price_display":"39.84","price_state":"stated","total_value":68997.5108,"total_display":"68,997.51","total_whole":"68,998","shares_owned_after":602.0,"shares_owned_after_display":"602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-03","filed_date":"2020-11-04","scope":"insider"},{"id":2883481,"accession":"0001209191-20-056953","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-056953","line_url":"/filing/0001209191-20-056953","is_derivative":false,"issuer_cik":"0001360548","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001360548","owner_cik":"0001360548","owner_name":"Tulipano Stephen J","owner_display_name":"Tulipano Stephen J","owner_url":"/insider/0001360548","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":37.249468542857144,"price_display":"37.25","price_state":"stated","total_value":1303731.399,"total_display":"1,303,731.40","total_whole":"1,303,731","shares_owned_after":15447.0,"shares_owned_after_display":"15,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-04","scope":"insider","n_lines":3},{"id":4522858,"accession":"0000899243-17-004750","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-004750","line_url":"/filing/0000899243-17-004750#line-1","is_derivative":false,"issuer_cik":"0001341235","issuer_name":"Aldeyra Therapeutics, Inc.","issuer_ticker":"ALDX","issuer_name_source":null,"issuer_url":"/issuer/0001341235","owner_cik":"0001360548","owner_name":"Tulipano Stephen J","owner_display_name":"Tulipano Stephen J","owner_url":"/insider/0001360548","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3333.0,"shares_display":"3,333","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":14998.5,"total_display":"14,998.50","total_whole":"14,999","shares_owned_after":3333.0,"shares_owned_after_display":"3,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-17","filed_date":"2017-02-21","scope":"insider"},{"id":7253093,"accession":"0000950117-10-000544","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950117-10-000544","line_url":"/filing/0000950117-10-000544#line-1","is_derivative":false,"issuer_cik":"0000050710","issuer_name":"JAVELIN PHARMACEUTICALS, INC","issuer_ticker":"JAV","issuer_name_source":null,"issuer_url":"/issuer/0000050710","owner_cik":"0001360548","owner_name":"Tulipano Stephen J","owner_display_name":"Tulipano Stephen J","owner_url":"/insider/0001360548","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock, par value $0.001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2385.0,"shares_display":"2,385","price_per_share":2.1801,"price_display":"2.18","price_state":"stated","total_value":5199.5385,"total_display":"5,199.54","total_whole":"5,200","shares_owned_after":22615.0,"shares_owned_after_display":"22,615","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-03","filed_date":"2010-05-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001623526","name":"Stoke Therapeutics, Inc.","url":"/issuer/0001623526","role":"Officer (CFO)","n_filings":3,"first_seen":"2020-11-04","last_seen":"2024-03-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001341235","name":"Aldeyra Therapeutics, Inc.","url":"/issuer/0001341235","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2017-02-21","last_seen":"2017-02-21"},{"type":"issuer","type_label":"ISSUER","cik":"0000050710","name":"JAVELIN PHARMACEUTICALS, INC","url":"/issuer/0000050710","role":"Officer (CFO and Secretary)","n_filings":1,"first_seen":"2010-05-05","last_seen":"2010-05-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001360548","retrieved_at":"2026-08-26T07:50:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}